Scilex Holding Company (SCLX)
NASDAQ: SCLX · IEX Real-Time Price · USD
0.951
+0.054 (5.97%)
At close: Apr 22, 2024, 4:00 PM
0.980
+0.028 (2.97%)
Pre-market: Apr 23, 2024, 8:00 AM EDT
Scilex Holding Company Market Cap
Scilex Holding Company has a market cap or net worth of $158.11 million as of April 23, 2024. Its market cap has decreased by -92.03% in one year.
Market Cap
158.11M
Enterprise Value
282.66M
1-Year Change
-92.03%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since January 7, 2021, Scilex Holding Company's market cap has increased from $127.60M to $158.11M, an increase of 23.91%. That is a compound annual growth rate of 6.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 19, 2024 | 149.20M | -0.27% |
| Apr 18, 2024 | 149.60M | -23.05% |
| Apr 17, 2024 | 194.40M | 0.83% |
| Apr 16, 2024 | 192.80M | -9.36% |
| Apr 15, 2024 | 212.70M | -3.76% |
| Apr 12, 2024 | 221.00M | 2.31% |
| Apr 11, 2024 | 216.00M | -3.01% |
| Apr 10, 2024 | 222.70M | -1.46% |
| Apr 9, 2024 | 226.00M | -2.16% |
| Apr 8, 2024 | 231.00M | -9.16% |
| Apr 5, 2024 | 254.30M | - |
| Apr 4, 2024 | 254.30M | -0.63% |
| Apr 3, 2024 | 255.90M | -0.66% |
| Apr 2, 2024 | 257.60M | -1.26% |
| Apr 1, 2024 | 260.90M | -1.25% |
| Mar 28, 2024 | 264.20M | -1.27% |
| Mar 27, 2024 | 267.60M | 6.66% |
| Mar 26, 2024 | 250.90M | 3.42% |
| Mar 25, 2024 | 242.60M | 1.38% |
| Mar 22, 2024 | 239.30M | 2.84% |
| Mar 21, 2024 | 232.70M | 2.96% |
| Mar 20, 2024 | 226.00M | 0.71% |
| Mar 19, 2024 | 224.40M | -1.45% |
| Mar 18, 2024 | 227.70M | - |
| Mar 15, 2024 | 227.70M | -1.43% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Candel Therapeutics | 162.59M |
| High Tide | 161.89M |
| ProQR Therapeutics | 161.63M |
| Orchestra BioMed Holdings | 161.00M |
| Harvard Bioscience | 160.58M |
| Quipt Home Medical | 157.88M |
| Inogen | 156.29M |
| Capricor Therapeutics | 155.62M |